2013 annual financial data
Corcept Therapeutics 2013 Operating margin
Direct answer
Operating margin was -400.66%.
Operating income was -41,496,000 USD and net income was -46,011,000 USD.
Operating cash flow was -37,058,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,357,000 USD
- Operating income
- -41,496,000 USD
- Net income
- -46,011,000 USD
- Operating cash flow
- -37,058,000 USD